Literature DB >> 8872523

Establishment of an experimental liver metastasis model by intraportal injection of a newly derived human pancreatic cancer cell line (KLM-1).

Y Kimura1, M Kobari, T Yusa, M Sunamura, M Kimura, H Shimamura, S Matsuno.   

Abstract

CONCLUSION: It is suggested that this liver metastasis model formed by a highly metastatic variant (KLM-1) is valuable for the study of the liver metastatic processes of human pancreatic cancer.
BACKGROUND: Liver metastasis in the early postoperative period is one of the causes for the poor prognosis of patients with resected pancreatic cancer. Therefore, it is necessary to establish an experimental model to study the mechanisms of liver metastasis in pancreatic cancer.
METHODS: Human pancreatic cancer cell lines (PK-1, PK-9, and KLM-1) were injected into the portal vein of nude mice with or without pretreatment with antiasialo GM1, and colonies of liver metastases were counted for comparison of metastatic ability of these cell lines. Biological and histopathological characteristics of the highly liver metastatic cell line (KLM-1) were compared with its parent cell line (PK-1).
RESULTS: PK-1 cells and PK-9 cells rarely formed liver metastasis foci, but pretreatment with antiasialo GM1 promoted liver metastasis. KLM-1 cells formed liver metastases at the rate of 70% even without antiasialo GM1 pretreatment. KLM-1 cells had such biological characteristics as short doubling time, short lag phase, and resistance to NK cytotoxicity. After intraportal injection of 125I-labeled KLM-1 cells, radioactivity as well as micrometastases were detected in the liver at 72 h.

Entities:  

Mesh:

Year:  1996        PMID: 8872523     DOI: 10.1007/bf02787375

Source DB:  PubMed          Journal:  Int J Pancreatol        ISSN: 0169-4197


  18 in total

1.  Metastasis of transplantable hepatomas from the spleen to the liver in mice.

Authors:  E H LEDUC
Journal:  Cancer Res       Date:  1959-11       Impact factor: 12.701

2.  Adhesiveness and morphology of Lewis lung carcinoma variants influence their sensitivity to natural killer cytolysis and their metastatic capacity.

Authors:  M R Young; G P Duffie; M Newby
Journal:  Invasion Metastasis       Date:  1987

3.  In vivo selection of highly metastatic cells from surgical specimens of different primary human colon carcinomas implanted into nude mice.

Authors:  K Morikawa; S M Walker; J M Jessup; I J Fidler
Journal:  Cancer Res       Date:  1988-04-01       Impact factor: 12.701

4.  Cancer of the pancreas. 50 years of surgery.

Authors:  B Gudjonsson
Journal:  Cancer       Date:  1987-11-01       Impact factor: 6.860

5.  In vivo effects of anti-asialo GM1. I. Reduction of NK activity and enhancement of transplanted tumor growth in nude mice.

Authors:  S Habu; H Fukui; K Shimamura; M Kasai; Y Nagai; K Okumura; N Tamaoki
Journal:  J Immunol       Date:  1981-07       Impact factor: 5.422

6.  Establishment of six human pancreatic cancer cell lines and their sensitivities to anti-tumor drugs.

Authors:  M Kobari; H Hisano; S Matsuno; T Sato; M Kan; T Tachibana
Journal:  Tohoku J Exp Med       Date:  1986-11       Impact factor: 1.848

7.  Experimental model for liver metastasis formation using Lewis lung tumor.

Authors:  L Kopper; T Van Hanh; K Lapis
Journal:  J Cancer Res Clin Oncol       Date:  1982       Impact factor: 4.553

8.  Role of natural killer cells in control of cancer metastasis.

Authors:  N Hanna
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

Review 9.  Rationale and methods for the use of nude mice to study the biology and therapy of human cancer metastasis.

Authors:  I J Fidler
Journal:  Cancer Metastasis Rev       Date:  1986       Impact factor: 9.264

10.  An in vivo study of hepatic and splenic interleukin-1 beta mRNA expression following oral PSK or LEM administration.

Authors:  H Morinaga; K Tazawa; H Tagoh; A Muraguchi; M Fujimaki
Journal:  Jpn J Cancer Res       Date:  1994-12
View more
  11 in total

1.  In vitro and in vivo activity of the low-immunogenic antimesothelin immunotoxin RG7787 in pancreatic cancer.

Authors:  Kevin Hollevoet; Emily Mason-Osann; Xiu-fen Liu; Sabine Imhof-Jung; Gerhard Niederfellner; Ira Pastan
Journal:  Mol Cancer Ther       Date:  2014-06-13       Impact factor: 6.261

2.  Combining the antimesothelin immunotoxin SS1P with the BH3-mimetic ABT-737 induces cell death in SS1P-resistant pancreatic cancer cells.

Authors:  Kevin Hollevoet; Antonella Antignani; David J Fitzgerald; Ira Pastan
Journal:  J Immunother       Date:  2014-01       Impact factor: 4.456

3.  Tofacitinib enhances delivery of antibody-based therapeutics to tumor cells through modulation of inflammatory cells.

Authors:  Nathan Simon; Antonella Antignani; Stephen M Hewitt; Massimo Gadina; Christine Alewine; David FitzGerald
Journal:  JCI Insight       Date:  2019-03-07

4.  Mesothelin Enhances Tumor Vascularity in Newly Forming Pancreatic Peritoneal Metastases.

Authors:  Leela Rani Avula; Michael Rudloff; Salma El-Behaedi; Danielle Arons; Rakan Albalawy; Xiongfong Chen; Xianyu Zhang; Christine Alewine
Journal:  Mol Cancer Res       Date:  2019-11-01       Impact factor: 5.852

5.  Keratinocyte growth factor induces matrix metalloproteinase-9 expression and correlates with venous invasion in pancreatic cancer.

Authors:  Kazumitsu Cho; Yoko Matsuda; Junji Ueda; Eiji Uchida; Zenya Naito; Toshiyuki Ishiwata
Journal:  Int J Oncol       Date:  2011-12-06       Impact factor: 5.650

6.  Gemcitabine induces poly (ADP-ribose) polymerase-1 (PARP-1) degradation through autophagy in pancreatic cancer.

Authors:  Yufeng Wang; Yasuhiro Kuramitsu; Kazuhiro Tokuda; Byron Baron; Takao Kitagawa; Junko Akada; Shin-ichiro Maehara; Yoshihiko Maehara; Kazuyuki Nakamura
Journal:  PLoS One       Date:  2014-10-01       Impact factor: 3.240

7.  Methylation-associated partial down-regulation of mesothelin causes resistance to anti-mesothelin immunotoxins in a pancreatic cancer cell line.

Authors:  Kevin Hollevoet; Emily Mason-Osann; Fabian Müller; Ira Pastan
Journal:  PLoS One       Date:  2015-03-24       Impact factor: 3.752

8.  Dominant Expression of DCLK1 in Human Pancreatic Cancer Stem Cells Accelerates Tumor Invasion and Metastasis.

Authors:  Hiromitsu Ito; Shinji Tanaka; Yoshimitsu Akiyama; Shu Shimada; Rama Adikrisna; Satoshi Matsumura; Arihiro Aihara; Yusuke Mitsunori; Daisuke Ban; Takanori Ochiai; Atsushi Kudo; Shigeki Arii; Shoji Yamaoka; Minoru Tanabe
Journal:  PLoS One       Date:  2016-01-14       Impact factor: 3.240

9.  Measles virus selectively blind to signaling lymphocyte activity molecule has oncolytic efficacy against nectin-4-expressing pancreatic cancer cells.

Authors:  Mutsumi Awano; Tomoko Fujiyuki; Koichiro Shoji; Yosuke Amagai; Yoshinori Murakami; Yoichi Furukawa; Hiroki Sato; Misako Yoneda; Chieko Kai
Journal:  Cancer Sci       Date:  2016-11       Impact factor: 6.716

10.  Protein Synthesis Inhibition Activity of Mesothelin Targeting Immunotoxin LMB-100 Decreases Concentrations of Oncogenic Signaling Molecules and Secreted Growth Factors.

Authors:  Salma El-Behaedi; Rebekah Landsman; Michael Rudloff; Emily Kolyvas; Rakan Albalawy; Xianyu Zhang; Tapan Bera; Keith Collins; Serguei Kozlov; Christine Alewine
Journal:  Toxins (Basel)       Date:  2018-10-31       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.